Summary
- Current Price
- As of today, KAPA price is $0.63, down -3.98% on
- Current Price All-Time High
- KAPA price is currently -84.25% below its historical high of $4.00 set on
- Market Cap
- KAPA current market cap is $13M, down -8.29% year-over-year
- PE Ratio
- KAPA PE ratio is unknown
- Revenue
- KAPA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for KAPA has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Kairos Pharma |
| Ticker | NYSEAmerican: KAPA |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kairospharma.com |
| Employees | 1 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.63 | ||
| Price, 1D Change | -3.98% | |
| $13M | ||
| - | ||
| - | ||
| 0.48 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.19 | ||
| EPS, 1Y Change | -34.30% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.19 | ||
| EPS Estimate | N/A | -$0.20 |
| EPS Est. Change | N/A | -5.54% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.63 | ||
| Price Target | - | $9.00 |
| Price Tgt. Change | - | +1,328.80% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.10 | -$0.19 | -89.50% | |
| -$0.20 | N/A | -5.54% | |
| -$0.33 | N/A | -74.14% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -39.43% | ||
| - | ||
| -8.29% | ||
| - | ||
| 0.00% | ||
| 0.00% | ||
| -34.30% | ||
| -13.47% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.63 | ||
| $0.90 | ||
| SMA 200 vs Price | +42.82% | |
| $0.70 | ||
| SMA 50 vs Price | +10.92% | |
| 0.48 | ||
| $0.06 | ||
| 47.79 | ||
| 103.62% | ||
| 119.99% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.19 | ||
| -$160.00K | ||
| - | ||
| -$2.34M | ||
| - | ||
| -$2.60M | ||
| - | ||
| -$2.18M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 4.20 | ||
| 4.20 | ||
| - | ||
| - | ||
| 2.83 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.70 | ||
| -1.41 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $4.78M | ||
| $1.27M | ||
| $6.22M | ||
| $4.17M | ||
| $1.44M | ||
| $992.00K | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $2.60M | ||
| $2.18M | ||
| $160.00K | ||
| $0.00 | ||
| $160.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$3.96M | ||
| $0.00 | ||
| $5.13M | ||
| $0.00 | ||
| -$3.96M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | ||
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with KAPA
FAQ
What is the ticker symbol for Kairos Pharma, Ltd.?
The ticker symbol for Kairos Pharma, Ltd. is NYSEAmerican:KAPA
Does Kairos Pharma, Ltd. pay dividends?
No, Kairos Pharma, Ltd. does not pay dividends
What sector is Kairos Pharma, Ltd. in?
Kairos Pharma, Ltd. is in the Healthcare sector
What industry is Kairos Pharma, Ltd. in?
Kairos Pharma, Ltd. is in the Biotechnology industry
What country is Kairos Pharma, Ltd. based in?
Kairos Pharma, Ltd. is headquartered in United States
When did Kairos Pharma, Ltd. go public?
Kairos Pharma, Ltd. initial public offering (IPO) was on September 16, 2024
Is Kairos Pharma, Ltd. in the S&P 500?
No, Kairos Pharma, Ltd. is not included in the S&P 500 index
Is Kairos Pharma, Ltd. in the NASDAQ 100?
No, Kairos Pharma, Ltd. is not included in the NASDAQ 100 index
Is Kairos Pharma, Ltd. in the Dow Jones?
No, Kairos Pharma, Ltd. is not included in the Dow Jones index
When was Kairos Pharma, Ltd. last earnings report?
Kairos Pharma, Ltd.'s most recent earnings report was on August 29, 2025
When does Kairos Pharma, Ltd. report earnings?
The date for Kairos Pharma, Ltd.'s next earnings report has not been announced yet
Data Sources & References
- KAPA Official Website kairospharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1962011/000164117225004920/0001641172-25-004920-index.htm
- KAPA Profile on Yahoo Finance finance.yahoo.com/quote/KAPA
- KAPA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kapa